This type of help/feedback is what the special "rolling review" is all about. It was about getting feedback early and tweaking it as we go.
We have been working closely with the FDA through
the BLA rolling review due to the novel nature of this product candidate and value the FDA’s
constructive feedback at this early stage in the process.
swapped my FMG shares I bought yesterday @ break-even and picked up 2000@ $18
GLTAH
Ann: BLA Filing Update for Renal Cancer Imaging Agent TLX250-CDx, page-30
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$23.47 |
Change
0.130(0.56%) |
Mkt cap ! $7.855B | |||
| Open | High | Low | Value | Volume |
| $23.82 | $23.99 | $23.23 | $28.94M | 1.231M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2801 | $23.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $23.50 | 7000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |